Townsend Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Townsend Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,764	Closed	-$352K	–	180
2025 Q1	$352K	Sell	5,764 -3,080	-35%	-$180K	0.14%	94
2024 Q4	$500K	Buy	8,844 +1,694	+24%	+$94.7K	0.18%	85
2024 Q3	$370K	Hold	7,150	–	–	0.14%	100
2024 Q2	$297K	Hold	7,150	–	–	0.12%	108
2024 Q1	$388K	Hold	7,150	–	–	0.15%	95
2023 Q4	$367K	Hold	7,150	–	–	0.17%	92
2023 Q3	$415K	Hold	7,150	–	–	0.21%	84
2023 Q2	$457K	Sell	7,150 -710	-9%	-$47.6K	0.22%	82
2023 Q1	$545K	Hold	7,860	–	–	0.28%	74
2022 Q4	$566K	Buy	7,860 +600	+8%	+$45.2K	0.28%	76
2022 Q3	$516K	Sell	7,260 -373	-5%	-$27.1K	0.29%	73
2022 Q2	$588K	Hold	7,633	–	–	0.3%	71
2022 Q1	$557K	Hold	7,633	–	–	0.27%	77
2021 Q4	$476K	Sell	7,633 -289	-4%	-$17K	0.23%	85
2021 Q3	$469K	Hold	7,922	–	–	0.25%	84
2021 Q2	$529K	Buy	7,922 +3,974	+101%	+$259K	0.29%	74
2021 Q1	$249K	Sell	3,948 -68	-2%	-$4.23K	0.15%	119
2020 Q4	$249K	Hold	4,016	–	–	0.17%	115
2020 Q3	$242K	Sell	4,016 -192	-5%	-$11.6K	0.2%	112
2020 Q2	$247K	Sell	4,208 -76	-2%	-$4.55K	0.2%	110
2020 Q1	$239K	Hold	4,284	–	–	0.25%	101
2019 Q4	$275K	Buy	+4,284	New	+$245K	0.22%	108

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Townsend Asset Management's BMY Position: Q2 2025 in Review

Townsend Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 5,764 shares — an estimated $352K sold.

Townsend Asset Management first reported a position in BMY in Q4 2019 and held it in 22 quarters. The position peaked at $588K in Q2 2022. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Townsend Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Townsend Asset Management sold 5,764 Bristol-Myers Squibb shares in Q2 2025, an estimated $352K.
Townsend Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 22 quarters.
Townsend Asset Management's Bristol-Myers Squibb position peaked at $588K in Q2 2022.
2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Townsend Asset Management's 13F filing for Q2 2025, filed 16 Jul 2025.